Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Jason John Luke
Based on 36 articles published since 2009
(Why 36 articles?)
||||
Expertise Level
The expertise of Jason John Luke ranks in the
  • Top 0.15%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 36 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Lüke, Julia   ·   Luke, Jason J   ·   Luke, Jason John   ·   Lüke, J   ·   Luke, Jason
Work Locations
Details
Most likely:    University of Chicago   Contact    
2019
  • Department of Medicine, The University of Chicago, Chicago, Illinois. · Center for Research Informatics, The University of Chicago, Chicago, Illinois. · Department of Pediatrics, The University of Chicago, Chicago, Illinois. · Department of Pathology, The University of Chicago, Chicago, Illinois. · Department of Medicine, The University of Chicago, Chicago, Illinois. · Pubmed 30635339
2018
  • Department of Cutaneous Oncology, Moffitt Cancer Center, 10920 McKinley Dr., MKC 4th 11.4123, Tampa, FL, 33612, USA. · Biological Sciences Division, University of Chicago, 5841 S. Maryland Ave., Chicago, IL, 60637, USA. · Department of Surgical Oncology, St. Louis University, 3655 Vista Ave., 1st Floor, St. Louis, MO, 63110, USA. · Department of Cutaneous Oncology, Moffitt Cancer Center, 10920 McKinley Dr., MKC 4th 11.4123, Tampa, FL, 33612, USA. · Pubmed 29722000
  • Department of Medicine, Medical University of South Carolina, Charleston, South Carolina. · Department of Medicine, University of Chicago, Chicago, Illinois. · Department of Radiology, Brigham and Women's Hospital. · Department of Biostatics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Dana-Farber Cancer Institute. · Department of Medicine, Beth Israel Deaconess Medical Center. · Department of Medicine, Massachusetts General Hospital Cancer Center. · Pubmed 30211813
  • Department of Pathology, University of Chicago, Chicago, IL 60637, USA. · Center for Research Informatics, University of Chicago, IL 60637, USA. · Department of Pediatrics, University of Chicago, IL 60637, USA. · Department of Medicine, University of Chicago, Chicago, IL 60637, USA. · Pubmed 29302014
  • Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Via Mariano Semmola snc, 80131, Naples, NA, Italy. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Istituto Nazionale Tumori-Fondazione "G. Pascale", Naples, Italy. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-Fondazione "G.Pascale", Naples, Italy. · "Regina Elena" National Cancer Institute, Rome, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Massachusetts General Hospital, Boston, MA, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The University of Chicago Medicine, Chicago, IL, USA. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Developmental Therapeutics Program, Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Immune Oncology Discovery and System Biology, AbbVie, Redwood City, CA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 30031393
2017
  • Department of Medicine, Division of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, 5841 South Maryland Avenue MC2115, Chicago, Illinois 60637, USA. · Department of Medicine, Harvard Medical School, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, Massachusetts 02114, USA. · Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles Jonsson Comprehensive Cancer Center, 10833 Le Conte Avenue, Los Angeles, California 90024, USA. · Melanoma Institute Australia, The University of Sydney, and The Mater Hospital, Rocklands Road, North Sydney, New South Wales 2060, Australia. · Royal North Shore Hospital, Reserve Road, St Leonards, New South Wales 2065, Australia. · Pubmed 28374786
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, University of Chicago, Chicago, Illinois. · Department of Medicine, Mayo Clinic Florida, Jacksonville, Florida. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 28396509
  • Department of Medical Oncology Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. · Harvard Medical School, Boston, Massachusetts. · Current affiliation: Merck; Merck & Co., Inc., Kenilworth, NJ, USA. · Department of Biostatistics, Boston University, Boston, Massachusetts. · Department of Medical Oncology Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 28373217
  • Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th floor, New York, NY, 10022, USA. · Weill Cornell Medical College, 1300 York Ave., New York, 10065, NY, USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. · University of Chicago Comprehensive Cancer Center, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA. · Mather Hospital, 12 Medical Drive, Suite D, Port Jefferson Station, NY, 11776, USA. · Spaulding Rehabilitation Hospital, 300 1st Ave., Charlestown, MA, 02113, USA. · Columbia University College of Physicians and Surgeons, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA. · Hofstra University, 1000 Fulton Ave, Hempstead, NY, 11549, USA. · The Gordon F. Derner Institute of Advanced Psychological Studies, Adelphi University, Hy-Weinberg Center, 1 South Avenue, Room 302, P.O. Box 701, Garden City, NY, 11530-0701, USA. · Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Room 1251, New York, NY, 10065, USA. · Mount Sinai Beth Israel, 325 West 15th Street, Room G11, New York, NY, 10011, USA. · Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, Av. Dr. Arnaldo, 251. 5th floor, São Paulo, 01246-000, Brazil. · Columbia University Medical Center, 161 Fort Washington Avenue, HIP 9, New York, NY, 10032, USA. · Pubmed 28247127
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
2016
  • University of Chicago Comprehensive Cancer Center, 5841 S. Maryland Ave. MC2115, Chicago, IL, 60637, USA. · University of Chicago Comprehensive Cancer Center, 5841 S. Maryland Ave. MC2115, Chicago, IL, 60637, USA. · Pubmed 27613168
  • Department of Pathology, University of Chicago, Chicago, IL 60637. · Department of Medicine, University of Chicago, Chicago, IL 60637. · Center for Research Informatics, University of Chicago, Chicago, IL 60637. · Human Immune Monitoring Facility, University of Chicago, Chicago, IL 60637. · Department of Pathology, University of Chicago, Chicago, IL 60637; · Pubmed 27837020
  • Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia. · Moffitt Cancer Center, Tampa, Florida. · Massachussetts General Hospital, Harvard Medical School, Boston, Massachusetts. · University of Chicago Comprehensive Cancer Center Chicago, Illinois. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Duke University School of Medicine, Durham, North Carolina. · Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, California. · Weill Cornell Medical College, New York, New York. · Pubmed 27533633
2015
  • Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA. · Melanoma Disease Center, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 25682878
  • Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. · Melanoma Disease Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Melanoma Disease Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. · Pubmed 25943535
  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Melanoma and Developmental Therapeutics Clinics, University of Chicago, Chicago, Illinois. · Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 25538262
Probable:    Harvard University Boston   Contact    
2018
  • Belfer Center for Applied Cancer Science. · Department of Medical Oncology, Dana-Farber Cancer Institute. · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 29406397
2015
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 25113308
  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Melanoma and Developmental Therapeutics Clinics, University of Chicago, Chicago, Illinois. · Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 25538262
  • King's College London School of Medicine, London, England. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Center for Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Melanoma Disease Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 25321335
  • Melanoma Disease Center of Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA · Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Melanoma Disease Center of Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Pubmed 24616309
2013
  • Dana-Farber Cancer Institute, Harvard Medical School, Melanoma Disease Center, Early Drug Development Center, Center for Immuno Oncology , 450 Brookline Ave, Boston, MA 02215 , USA +1 6176324715 ; +1 6176326727 ; · Pubmed 24138302
  • Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA. · Pubmed 23709751
  • F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute · Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital · Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA · Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and Oregon Health & Science University, Portland, OR · Philip Friedlander, Mount Sinai Medical Center, New York, NY · Rene Gonzalez, University of Colorado Cancer Center, Aurora, CO · Jeffrey S. Weber, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL · Thomas F. Gajewski, University of Chicago, Chicago, IL · Steven J. O'Day, Beverly Hills Cancer Center, Beverly Hills, CA · Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX · Frances A. Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC · and Marc S. Ernstoff, Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH. · Pubmed 23775962
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23913718
  • Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Pubmed 23411478
Probable:    Christian-Albrechts-Universitat zu Kiel      
2017
  • Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Lübeck. · Pubmed 28192844
2011
  • Department of Ophthalmology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Pubmed 21279973
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 36 total) written by Jason John Luke about Melanoma:

  • WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers. 2019
  • Review of diagnostic, prognostic, and predictive biomarkers in melanoma. 2018
  • Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma. 2018
  • Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization. 2018
  • The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. 2018
  • Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy). 2018
  • Targeted agents and immunotherapies: optimizing outcomes in melanoma. 2017
  • [Potentials and Limitations of the Detection of Circulating Melanoma Cells]. 2017
  • Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced Melanoma. 2017
  • Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients. 2017
Show List of Full Article Records
Google Searches

Learn more about Jason John Luke using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Chicago
Harvard University Boston
Christian-Albrechts-Universitat zu Kiel
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Chicago
2019
  • Department of Medicine, The University of Chicago, Chicago, Illinois. · Center for Research Informatics, The University of Chicago, Chicago, Illinois. · Department of Pediatrics, The University of Chicago, Chicago, Illinois. · Department of Pathology, The University of Chicago, Chicago, Illinois. · Department of Medicine, The University of Chicago, Chicago, Illinois. · Pubmed 30635339
2018
  • Department of Cutaneous Oncology, Moffitt Cancer Center, 10920 McKinley Dr., MKC 4th 11.4123, Tampa, FL, 33612, USA. · Biological Sciences Division, University of Chicago, 5841 S. Maryland Ave., Chicago, IL, 60637, USA. · Department of Surgical Oncology, St. Louis University, 3655 Vista Ave., 1st Floor, St. Louis, MO, 63110, USA. · Department of Cutaneous Oncology, Moffitt Cancer Center, 10920 McKinley Dr., MKC 4th 11.4123, Tampa, FL, 33612, USA. · Pubmed 29722000
  • Department of Medicine, Medical University of South Carolina, Charleston, South Carolina. · Department of Medicine, University of Chicago, Chicago, Illinois. · Department of Radiology, Brigham and Women's Hospital. · Department of Biostatics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Dana-Farber Cancer Institute. · Department of Medicine, Beth Israel Deaconess Medical Center. · Department of Medicine, Massachusetts General Hospital Cancer Center. · Pubmed 30211813
  • Department of Pathology, University of Chicago, Chicago, IL 60637, USA. · Center for Research Informatics, University of Chicago, IL 60637, USA. · Department of Pediatrics, University of Chicago, IL 60637, USA. · Department of Medicine, University of Chicago, Chicago, IL 60637, USA. · Pubmed 29302014
  • Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Via Mariano Semmola snc, 80131, Naples, NA, Italy. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Istituto Nazionale Tumori-Fondazione "G. Pascale", Naples, Italy. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-Fondazione "G.Pascale", Naples, Italy. · "Regina Elena" National Cancer Institute, Rome, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Massachusetts General Hospital, Boston, MA, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The University of Chicago Medicine, Chicago, IL, USA. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Developmental Therapeutics Program, Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Immune Oncology Discovery and System Biology, AbbVie, Redwood City, CA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 30031393
2017
  • Department of Medicine, Division of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, 5841 South Maryland Avenue MC2115, Chicago, Illinois 60637, USA. · Department of Medicine, Harvard Medical School, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, Massachusetts 02114, USA. · Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles Jonsson Comprehensive Cancer Center, 10833 Le Conte Avenue, Los Angeles, California 90024, USA. · Melanoma Institute Australia, The University of Sydney, and The Mater Hospital, Rocklands Road, North Sydney, New South Wales 2060, Australia. · Royal North Shore Hospital, Reserve Road, St Leonards, New South Wales 2065, Australia. · Pubmed 28374786
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, University of Chicago, Chicago, Illinois. · Department of Medicine, Mayo Clinic Florida, Jacksonville, Florida. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 28396509
  • Department of Medical Oncology Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. · Harvard Medical School, Boston, Massachusetts. · Current affiliation: Merck; Merck & Co., Inc., Kenilworth, NJ, USA. · Department of Biostatistics, Boston University, Boston, Massachusetts. · Department of Medical Oncology Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 28373217
  • Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th floor, New York, NY, 10022, USA. · Weill Cornell Medical College, 1300 York Ave., New York, 10065, NY, USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. · University of Chicago Comprehensive Cancer Center, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA. · Mather Hospital, 12 Medical Drive, Suite D, Port Jefferson Station, NY, 11776, USA. · Spaulding Rehabilitation Hospital, 300 1st Ave., Charlestown, MA, 02113, USA. · Columbia University College of Physicians and Surgeons, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA. · Hofstra University, 1000 Fulton Ave, Hempstead, NY, 11549, USA. · The Gordon F. Derner Institute of Advanced Psychological Studies, Adelphi University, Hy-Weinberg Center, 1 South Avenue, Room 302, P.O. Box 701, Garden City, NY, 11530-0701, USA. · Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Room 1251, New York, NY, 10065, USA. · Mount Sinai Beth Israel, 325 West 15th Street, Room G11, New York, NY, 10011, USA. · Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, Av. Dr. Arnaldo, 251. 5th floor, São Paulo, 01246-000, Brazil. · Columbia University Medical Center, 161 Fort Washington Avenue, HIP 9, New York, NY, 10032, USA. · Pubmed 28247127
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
2016
  • University of Chicago Comprehensive Cancer Center, 5841 S. Maryland Ave. MC2115, Chicago, IL, 60637, USA. · University of Chicago Comprehensive Cancer Center, 5841 S. Maryland Ave. MC2115, Chicago, IL, 60637, USA. · Pubmed 27613168
  • Department of Pathology, University of Chicago, Chicago, IL 60637. · Department of Medicine, University of Chicago, Chicago, IL 60637. · Center for Research Informatics, University of Chicago, Chicago, IL 60637. · Human Immune Monitoring Facility, University of Chicago, Chicago, IL 60637. · Department of Pathology, University of Chicago, Chicago, IL 60637; · Pubmed 27837020
  • Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia. · Moffitt Cancer Center, Tampa, Florida. · Massachussetts General Hospital, Harvard Medical School, Boston, Massachusetts. · University of Chicago Comprehensive Cancer Center Chicago, Illinois. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Duke University School of Medicine, Durham, North Carolina. · Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, California. · Weill Cornell Medical College, New York, New York. · Pubmed 27533633
2015
  • Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA. · Melanoma Disease Center, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 25682878
  • Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. · Melanoma Disease Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Melanoma Disease Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. · Pubmed 25943535
  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Melanoma and Developmental Therapeutics Clinics, University of Chicago, Chicago, Illinois. · Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 25538262
Harvard University Boston
2018
  • Belfer Center for Applied Cancer Science. · Department of Medical Oncology, Dana-Farber Cancer Institute. · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 29406397
2015
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 25113308
  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Melanoma and Developmental Therapeutics Clinics, University of Chicago, Chicago, Illinois. · Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 25538262
  • King's College London School of Medicine, London, England. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Center for Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Melanoma Disease Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 25321335
  • Melanoma Disease Center of Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA · Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Melanoma Disease Center of Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Pubmed 24616309
2013
  • Dana-Farber Cancer Institute, Harvard Medical School, Melanoma Disease Center, Early Drug Development Center, Center for Immuno Oncology , 450 Brookline Ave, Boston, MA 02215 , USA +1 6176324715 ; +1 6176326727 ; · Pubmed 24138302
  • Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA. · Pubmed 23709751
  • F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute · Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital · Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA · Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and Oregon Health & Science University, Portland, OR · Philip Friedlander, Mount Sinai Medical Center, New York, NY · Rene Gonzalez, University of Colorado Cancer Center, Aurora, CO · Jeffrey S. Weber, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL · Thomas F. Gajewski, University of Chicago, Chicago, IL · Steven J. O'Day, Beverly Hills Cancer Center, Beverly Hills, CA · Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX · Frances A. Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC · and Marc S. Ernstoff, Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH. · Pubmed 23775962
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23913718
  • Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Pubmed 23411478
Christian-Albrechts-Universitat zu Kiel
2017
  • Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Lübeck. · Pubmed 28192844
2011
  • Department of Ophthalmology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Pubmed 21279973
Universitat Lubeck
2016
  • Department of Ophthalmology, University of Lübeck, Lübeck, Germany. · Department of Pathology, University of Lübeck, Lübeck, Germany. · Department of Ophthalmology, University of Lübeck, Lübeck, Germany. · Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27390171
  • Department of Ophthalmology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. · Department of Ophthalmology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. · University Eye Hospital, Centre of Ophthalmology, Eberhard-Karls University of Tuebingen, Tuebingen, Germany. · Pubmed 27255356
  • Klinik für Augenheilkunde, Universität zu Lübeck. · Department für Augenheilkunde, Forschungsbereich Geschichte der Augenheilkunde/Ophthalmopathologisches Labor, Eberhard-Karls-Universität Tübingen. · Pubmed 26854480
  • Department of Ophthalmology, University of Lübeck, Lübeck, Germany. · University Eye Hospital, Centre of Ophthalmology, Eberhard-Karls University of Tuebingen,, Tuebingen, Germany. · Pubmed 26590370
2014
  • Department of Ophthalmology, University of Lübeck, Lübeck, Germany. · Department of Pathology, University of Lübeck, Lübeck, Germany. · Department of Ophthalmology, J3-S, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 24970258
2011
  • Department of Ophthalmology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Pubmed 21279973
Memorial Sloan-Kettering Cancer Center
2013
  • Department of Medicine, Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23608448
2012
  • Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA. · Pubmed 22083257
2013
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 23716015
NewYork-Presbyterian Hospitals
2012
  • Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA. · Pubmed 22083257
Yearly article counts 15677171100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.